This translocation and eventual formation of the fusion protein NPM-ALK is the definitive molecular feature of ALK+ ALCL, whereas the other subgroup, that is, ALK− ALCL, is coarsely defined as cases devoid of expressing the fusion protein NPM-ALK. The gene discussed is NPM1; the disease is anaplastic large cell lymphoma.